We have isolated a cDNA clone encoding the Xenopus homologue of the transcription factor AP-2 (XAP-2). The predicted amino acid sequence derived from the Xenopus cDNA shows very strong conservation with the amino acid sequence of human AP-2, suggesting that this protein is evolutionarily conserved, at least among vertebrates. This is further substantiated by the demonstration that an in vitro translation product of XAP-2 cDNA bound specifically to an AP-2 binding site from the human MT-IIA gene. Northern blot analysis of Xenopus embryo RNA revealed the existence of three major XAP-2 mRNA species that were only detectable after the midblastula transition (when embryonic transcription is activated), with peak accumulation of the transcripts occurring during gastrulation. Therefore, in contrast to other Xenopus transcription factors, XAP-2 is not maternally derived but arises exclusively from zygotic transcription. Unlike the situation in cultured human teratocarcinoma (NT2) cells, retinoic acid treatment did not induce XAP-2 mRNA in Xenopus embryos, even though the treatment had a pronounced morphogenetic effect on the embryos. Our results suggest that XAP-2 may play a distinctive role during Xenopus embryogenesis.
INTRODUCTION
One useful approach for analyzing regulation of gene expression in higher eukaryotes is the study of trans-acting protein factors that modulate transcription rate through binding to a gene's cisacting DNA elements. Certain of such transcription factors have been shown to have their expression or activity regulated in a cell-type-specific, tissue-specific, or cell-cycle-dependent fashion (1-4; for review, see 5) . Few transcription factors, however, have been shown to be regulated during embryonic development. In Xenopus, most transcription factors responsible for gene expression at the onset of embryonic transcription, a stage called the midblastula transition (MBT; [6] [7] [8] , are believed to be maternal in origin. Proteins binding to CCAAT and ATF/AP-1-like sequences have been found in nuclear extracts from early blastula embryos (9) , a binding activity specific for the cardiac actin CArG promoter element is present in unfertilized eggs (2) , and heat-activatable heat shock transcription factor (HSF) activity has been demonstrated in unfertilized eggs and early embryos (10) . All of these factors, since they are present before embryonic transcription is active, must be produced from maternal mRNA synthesized in the oocyte.
One transcription factor that may play a role in development is AP-2. This protein was first identified and purified from HeLa cells as a 50-52 kDa binding activity that recognized sequences common to the enhancer elements of SV40 and the human metallothionein-IIA (hMT-IIA) gene (11) (12) (13) and stimulated transcription in vitro of gene constructions containing the hMT-IIA promoter (12, 13) . Binding sites for AP-2 have been found in a number of other human protein-coding genes, including proenkephalin (14) , collagenase (15) , growth hormone (12) , and c-myc (12) . From comparison of twelve such binding sites, a consensus sequence of 5'-CCCCAGGC-3' has been determined (13) , although individual sites may vary substantially from the consensus. More recently, a cDNA encoding human AP-2 was cloned from a HeLa cDNA library (16) .
AP-2 expression has been shown to be stimulated transiently during retinoic acid-induced differentiation of NT2 human teratocarcinoma cells (16, 17) . Retinoic acid is a morphogen involved in vertebrate limb bud pattern formation (18) (19) (20) , so response of AP-2 expression to this morphogen has led to the proposal that AP-2 may have an important role in regulating gene expression in early development (16) . In Xenopus, retinoic acid has also been shown to affect embryonic primary axis formation (21) and anteroposterior patterning of the central nervous system (22) .
In this paper, we report the cloning of a Xenopus cDNA that is homologous to human AP-2 cDNA. (Fig. iB) . The two sequences differ at the amino terminus, but overall show 88.1% identity at the amino acid level. If conservative amino acid substitutions are allowed, the degree of similarity between the two sequences is 92.7%. Because of this high degree of conservation, we believe that the cDNA we isolated encodes Xenopus AP-2 (XAP-2).
To further substantiate our claim that our cDNA encodes XAP-2, we subcloned a PCR-amplified segment (containing the entire open reading frame) of clone XAP2 -6a in frame into the T7 expression vector pET-3c (25) . This construction was transcribed in vitro using T7 polymerase and the resulting RNA was translated in vitro in a rabbit reticulocyte lysate. Translation products were analyzed by SDS-PAGE, shown in Fig. 2A (Fig. 3A) . The probe used in these studies was a 1 kbp Eco RI fragment from clone XAP2-6a (represented by a hatched box in Fig. IA) A To determine if XAP-2 transcripts were present at any point during oogenesis, RNA from defolliculated oocytes of mixed stages was blotted along with RNA from egg and three embryonic stages (Fig. 3B) . Even after overexposing the blot, no XAP-2 mRNA was observed in ovary, egg, or stage 8 samples (lanes l-3). To ensure even RNA loading and the integrity of the RNA samples, both blots in Fig. 3 were stripped of XAP-2 probe and rehybridized with a probe from the cDNA clone r5, which represents an unidentified ubiquitous RNA (31) . From this reprobing, intact RNA was confirmed in all lanes (data not shown). It appears, therefore, that XAP-2 gene expression does not occur during oogenesis, but commences only after the midblastula transition.
The presence of multiple XAP-2 mRNA species in embryos raised the possibility of a family of AP-2 genes in Xenopus. To explore this possibility, we performed a Southern blot of homozygous Xenopus DNA digested with various enzymes and probed with the XAP-2 probe (Fig. 4) . In most digested samples, the XAP-2 probe hybridized to several bands of large size (lane 1 in particular). The observed DNA band sizes suggest that at least two, but probably not more than four, XAP-2 genes exist. Isolation and characterization of genomic clones will be required to clarify the relationship between the multiple mRNAs and genomic XAP-2 DNA.
Because human AP-2 expression was reported to be stimulated by retinoic acid (RA; 16, 17) , and because RA has been shown to affect Xenopus embryonic development (21, 22) , we tested whether XAP-2 expression could be induced by RA in developing embryos. Embryos were exposed to 1 ptM RA beginning at stage 9, the period during which Xenopus embryos are the most sensitive to the morphological effects of RA (21), and RNA was prepared from the embryos at various times thereafter. As demonstrated in Fig. 5 , RA treatment of embryos under these conditions did not significantly increase accumulation of XAP-2 mRNA (lanes 1 -12) . We did observe a decrease in XAP-2 expression upon RA treatment for 2 h (lane 6 compared to the control in lane 5) and for 6 h (lane 8 compared to lane 7). In -UE these two cases control embryos at the time of sampling were at stage 10 and stage 11, respectively, both of which correspond to early gastrulation, when XAP-2 mRNA shows its highest accumulation. It has been shown by Sive et al. (21) that RA retards development of Xenopus embryos during gastrulation. Conceivably, development of the RA-treated embryos may have lagged behind the control embryos sufficiently that they had not yet experienced the major increase in XAP-2 mRNA accumulation. This would result in RA-treated embryos showing an apparent decrease in XAP-2 mRNA levels compared to controls. The same result was not observed for embryos sampled at later stages because by those stages, XAP-2 mRNA accumulation has decreased and does not show as pronounced a change in so short a time period.
In case a transient period of XAP-2 inducibiity was being missed earlier in development, we also tried adding RA to embryos soon after fertilization (four-cell stage) and allowing exposure to continue for 24 h (lanes 13 and 14) , but XAP-2 expression was still not affected. Several other treatment programs were tried, such as 40 h of exposure to RA beginning at stage 9, 2 h of exposure beginning at stage 9 followed by removal of RA and recovery of embryos for various periods up to 40 h, and 2 h of exposure beginning at four-cell stage followed by removal of RA and recovery of embryos for 24 h. None of these approaches had any reproducible effect on XAP-2 gene expression (data not shown). While our list of treatment regimens was not exhaustive, enough different conditions were tried that we feel confident concluding that general XAP-2 expression is not readily induced by RA in embryos. The lack of induction of XAP-2 could not be attributed to inaction of the RA because all but the shortest exposures to the drug resulted in major morphological abnormalities, with virtually all embryos having a dorsoanterior index (21) of 1 to 2 (data not shown). We cannot rule out that within embryos a subset of cells responded to RA treatment with increased XAP-2 expression; in situ hybridization with the XAP-2 probe will be required to investigate this possibility. 1 Regardless of the nature of the origin of the three transcripts, their existence is intriguing. Their size differences may be due to additional coding sequence present in the larger transcripts, which would suggest differences in function between the translation products, or to transcripts having different amounts of untranslated RNA, which, as discussed above, would raise the possibility of differential post-transcriptional regulation of XAP-2 gene expression. The latter possibility is consistent with the observation that the three XAP-2 mRNA species differ slightly in their patterns of developmental expression. No matter which explanation is correct (they are not mutually exclusive), the presence of multiple XAP-2 mRNAs that are regulated differently suggest that this factor plays more than a simple role during Xenopus embryogenesis.
What that role might be is still far from certain, but inferences can be drawn from our data. Unlike other Xenopus transcription factors, XAP-2 does not appear to be synthesized maternally; the earliest point in development that any of the XAP-2 transcripts was detected was stage 9, after the midblastula transition. Because XAP-2 mRNA is not detected in the embryo until after the MBT, this factor is unlikely to be directly involved in the general transcriptional activation that occurs at the MBT. Peak accumulation of two of the XAP-2 mRNA species (the 1.8 kb and 2.2 kb transcripts) occurred during gastrulation, implying that an important aspect of the factor's function occurs at this stage. XAP-2 might therefore regulate genes activated not at the MBT but sometime thereafter. Thus XAP-2 may constitute part of a second wave of transcriptional regulators that have more specialized roles in the embryo.
As stated in the Introduction, AP-2 mRNA accumulation has been shown to increase in retinoic acid-induced human teratocarcinoma cells (16, 17) . Furthermore, a recent publication by Mitchell et al. (37) proposed that AP-2 has a role in transcriptional regulation during retinoid-affected morphogenetic processes, because AP-2 mRNA was localized to mouse embryonic tissues that are developmentally sensitive to retinoic acid. However, treatment of Xenopus embryos with retinoic acid did not result in increased XAP-2 mRNA accumulation, even though the treated embryos showed substantial morphological abnormalities. While XAP-2 may be involved in regulating some morphogenetic processes affected by RA in Xenopus embryos, our results clearly indicate that RA-induced developmental aberrations in frog embryos do not depend on activation of the XAP-2 gene. The availability of the XAP-2 clone will enable us to further explore the developmental regulation of this factor, and how this regulation contributes to the proper effectuation of the complex program of gene expression that directs embryonic development.
